| Literature DB >> 20109216 |
Helen E Gruber1, Gretchen L Hoelscher, Jane A Ingram, Natalia Zinchenko, Edward N Hanley.
Abstract
BACKGROUND: Senescent cells are well-recognized in the aging/degenerating human disc. Senescent cells are viable, cannot divide, remain metabolically active and accumulate within the disc over time. Molecular analysis of senescent cells in tissue offers a special challenge since there are no cell surface markers for senescence which would let one use fluorescence-activated cell sorting as a method for separating out senescent cells.Entities:
Mesh:
Year: 2010 PMID: 20109216 PMCID: PMC2828399 DOI: 10.1186/1472-6750-10-5
Source DB: PubMed Journal: BMC Biotechnol ISSN: 1472-6750 Impact factor: 2.563
Demographic Features of Subjects and Percentages of Senescent Cells *
| Subject Number | % Senescent Cells ** | Age | Gender | Site | Thompson |
|---|---|---|---|---|---|
| 1 | 68.1 | 28 | Female | L3-L4 | 3 |
| 2 | 76.4 | 46 | Female | L4-L5 | 4 |
| 3 | 71.8 | 56 | Male | L4-L5 | 4 |
| 4 | 74.5 | 45 | Male | L5-S1 | 4 |
| 5 | 80.2 | 54 | Female | C4-C5 | 4 |
| 6 | 92.0 | 32 | Male | L5-S1 | 4 |
| 7 | 64.4 | 56 | Male | L4-L5 | 5 |
| 8 | 68.6 | 37 | Male | L4-L5 | 3.5 |
| 9 | 57.1 | 57 | Male | L4-L5 | 3 |
| 10 | 46.1 | 26 | Female | L5-S1 | 3 |
| 11 | 51.8 | 37 | Male | L5-S1 | 3 |
* * L, lumbar; S, sacral; C, cervical.
** Determined from measurement of senescent cells (using SA-β-gal immunohistochemistry) on sections adjacent to those used for LCM.
Figure 1A: Localization of senescent cells (red; bold arrows) and non-senescent cells (thin arrows) using immunofluorescent localization of senescent-associated-β-galactosidase in paraffin-embedded human annulus tissue. (Bar = 10 μm). B: No significant difference was identified in vitro when control or H2O2-treated annulus cells were quantified using histochemical (H) vs. the immunofluoresce (I) method to detect senescent cells.
Senescence-Related Genes with Significant Differences in Gene Expression Levels in Senescent vs. Non-Senescent Annulus Cells
| Gene Name | Ratio/Fold Change | Direction | P value | Gene Identifier |
|---|---|---|---|---|
| RB-associated KRAB zinc finger | 1.51 | Up | 0.022 | |
| Discoidin, CUB and LCCL domain containing protein 2 | 1.47 | Up | 0.038 | |
| p38 (p38 MAP kinase; MPAK14) | 1.37 | Up | 0.029 | |
| Inhibitor of growth family, member 5 (p28ING5) | 1.18 | Up | 0.046 | |
| Growth arrest and DNA-damage-inducible, beta | 1.06 | Up | 0.040 | |
| Somatostatin receptor 3 | 1.03 | Up | 0.048 | |
| Interferon induced transmembrane protein 1 (9-27) | 1.08 | Up | 0.038 | |
| Sphingosine-1-phosphate receptor 2 | 1.38 | Up | 0.046 | |
| Cyclin-dependent kinase 8 (CDK8) | 1.12 | Down | 0.049 | |
| Nitric oxide synthase 1 | 1.06 | Down | 0.017 | |
| Heat shock 70 kDa protein 6 (HSP70B) | 1.11 | Down | 0.020 | |
Cell Proliferation or Cell Cycle Genes with Significant Expression Differences in Senescent vs. Non-Senescent Annulus Cells
| Gene Name | Ratio/Fold Change | Direction | P value | Gene Identifier |
|---|---|---|---|---|
| Protein tyrosine phosphatase, receptor type, A | 1.68 | Up | 0.043 | |
| Kallikrein-related peptidase 4 | 1.44 | Up | 0.025 | |
| Leucine zipper, putative tumor suppressor 1 | 1.35 | Up | 0.033 | |
| Leucine zipper, putative tumor suppressor 1 | 1.35 | Up | 0.033 | |
| SPEG complex locus | 1.26 | Up | 0.040 | |
| KIAA1009 | 1.25 | Up | 0.042 | |
| Bone morphogenetic protein receptor, type II (serine/threonine kinase) | 1.15 | Up | 0.023 | |
| Pyrin and HIN domain family, member 1 | 1.58 | Down | 0.005 | |
| Alpha-2-glycoprotein 1, zinc-binding | 1.23 | Down | 0.041 | |
| Arachidonate 15-lipoxygenase | 1.21 | Down | 0.040 | |
| Ras homolog gene family, member H | 1.17 | Down | 0.046 | |
| Cell division cycle 2-like 6 (CDK8-like) | 1.16 | Down | 0.016 | |
| Tumor necrosis factor (ligand) superfamily, member 13b | 1.13 | Down | 0.024 | |
| Triple functional domain (PTPRF interacting) | 1.13 | Down | 0.027 | |
| Sialophorin (leukosialin, CD43) | 1.07 | Down | 0.042 | |
| G1 to S phase transition 2 | 1.04 | Down | 0.018 | |